Gayatinea, Baby Boy M.
HRN: 21-65-43 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/29/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/29/2022
08/04/2022
IV
35mg
OD
Neonatal Sepsis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes